Here are four insights:
1. Dr. Tally injected Vivex Biomedical’s MIAMI adult stem cells into a patient’s dehydrated intervertebral discs.
2. This case was the first spine procedure to use these stem cells.
3. Athens Orthopedic Clinic is a research site for the MIAMI cells.
4. The MIAMI cells are inducible and potent.
“The outcomes of the procedure will hopefully improve the patient’s back symptoms by bending the curve of the normal trajectory of early disc degeneration,” said Dr. Tally.
More articles on devices:
Antibe Therapeutics launches PentOS OI Putty — 5 highlights
SpinalCyte publishes research findings in Global Spine Journal — 3 notes
Amedica breaks into Chinese market with Shandong Weigao partnership: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
